JMD TIDES - Oligonucleotide and Peptide - May 18-21, 2008, Las Vegas, NV
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schrijver, I.
Right arrow Articles by Kammesheidt, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schrijver, I.
Right arrow Articles by Kammesheidt, A.
JMD 2005, Vol. 7, No. 2
Copyright © 2005 American Society for Investigative Pathology & Association for Molecular Pathology

Diagnostic Testing by CFTR Gene Mutation Analysis in a Large Group of Hispanics

Novel Mutations and Assessment of a Population-Specific Mutation Spectrum

Iris Schrijver*, Sudha Ramalingam{dagger}, Ramalingam Sankaran{dagger}, Steve Swanson{ddagger}, Charles L.M. Dunlop{ddagger}, Steven Keiles{ddagger}, Richard B. Moss§, John Oehlert, Phyllis Gardner{dagger}, E. Robert Wassman{ddagger} and Anja Kammesheidt{ddagger}

From the Departments of Pathology, * Medicine, {dagger} and Pediatrics, § Stanford University Medical Center, Stanford; Ambry Genetics Corporation, {ddagger} Irvine; and FRI Solutions Incorporated, Half Moon Bay, California

Characterization of CFTR mutations in the U.S. Hispanic population is vital to early diagnosis, genetic counseling, patient-specific treatment, and the understanding of cystic fibrosis (CF) pathogenesis. The mutation spectrum in Hispanics, however, remains poorly defined. A group of 257 self-identified Hispanics with clinical manifestations consistent with CF were studied by temporal temperature gradient electrophoresis and/or DNA sequencing. A total of 183 mutations were identified, including 14 different amino acid-changing novel variants. A significant proportion (78/85) of the different mutations identified would not have been detected by the ACMG/ACOG-recommended 25-mutation screening panel. Over one third of the mutations (27/85) occurred with a relative frequency >1%, which illustrates that the identified mutations are not all rare. This is supported by a comparison with other large CFTR studies. These results underscore the disparity in mutation identification between Caucasians and Hispanics and show utility for comprehensive diagnostic CFTR mutation analysis in this population.




This article has been cited by other articles:


Home page
ChestHome page
V. Kaza, M. F. Katz, S. Cumming, A. E. Frost, and Z. Safdar
Correlation of Chest Radiograph Pattern With Genotype, Age, and Gender in Adult Cystic Fibrosis: A Single-Center Study
Chest, August 1, 2007; 132(2): 569 - 574.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
E. Elahi, A. Khodadad, I. Kupershmidt, F. Ghasemi, B. Alinasab, R. Naghizadeh, R. G. Eason, M. Amini, M. Esmaili, M. R. Esmaeili Dooki, et al.
A Haplotype Framework for Cystic Fibrosis Mutations in Iran
J. Mol. Diagn., February 1, 2006; 8(1): 119 - 127.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology and the Association for Molecular Pathology.